Response to ASX Price Query
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Amplia Therapeutics Ltd. has responded to a price query from the ASX regarding recent trading activity in its securities, confirming it is not aware of any undisclosed information that could explain the trading changes. The company stated it is complying with the ASX Listing Rules and that its responses were authorized by the Managing Director.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Amplia Therapeutics Ltd. on 6ix
Earlier from Amplia Therapeutics
- Amplia Presents at CG Drug and Device Conference 2026
- Amplia Presents at E&P Healthcare Conference 2026
- Amplia and ANZGOG Finalise Protocol for Ovarian Cancer Trial
- Notification regarding unquoted securities - ATX
- Results of Annual General Meeting
Later from Amplia Therapeutics
- Amplia Therapeutics Provides Clinical Trial Updates
- Amplia Receives R&D Tax Rebate Totalling $4.78 Million
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Amplia Therapeutics into a list and get an email when it puts out news.
Follow Amplia Therapeutics